Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

4(57%)

Results Posted

100%(1 trials)

Terminated

2(29%)

Phase Distribution

Ph phase_2

43%

Ph not_applicable

29%

Ph phase_3

29%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 2Efficacy & side effects

3(42.9%)

Phase 3Large-scale testing

2(28.6%)

N/ANon-phased studies

2(28.6%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(1)

Terminated(2)

Detailed Status

Active, not recruiting3

Terminated2

Recruiting1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 3

Trials by Phase

Phase 23 (42.9%)

Phase 32 (28.6%)

N/A2 (28.6%)

Trials by Status

recruiting114%

terminated229%

active_not_recruiting343%

completed114%

Recent Activity

4 active trials

Showing 5 of 7

active_not_recruitingphase_2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

NCT03227146

active_not_recruitingphase_2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

NCT03229564

active_not_recruitingphase_2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

NCT03394612

recruitingphase_3

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

NCT06745557

terminatednot_applicable

The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect

NCT02980601

View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials

NCT03227146Phase 2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

Active Not Recruiting

NCT03229564Phase 2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Children

Active Not Recruiting

NCT03394612Phase 2

Study With an Autologous Dermo-epidermal Skin Substitute for the Treatment of Full-Thickness Skin Defects in Adults and Children

Active Not Recruiting

NCT06745557Phase 3

Phase III Study with an Autologous Dermo-epidermal Skin Substitute for the Treatment of Burns in Adults and Adolescents

Recruiting

NCT02980601Not Applicable

The Use of Integra in Coverage of Radial Forearm Free Flap Donor Site Defect

Terminated

NCT03526913Not Applicable

Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers

Completed

NCT01616043Phase 3

Glyaderm Clinical Evaluation Multicenter Study

Terminated

All 7 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 7